retatrutide dose chart Dosing Guide: 1-12 mg Weekly Triple Agonist (2026) starting dose for retatrutide Half

A 2025 study found that tripling semaglutides dose to 7.2 mg led to roughly 19% weight loss over 72 weeks, compared to 16% at the standard dose, a meaningful gain, though with higher rates of side effects

Back Holst, JJ (2024) The Story of GLP-1: A historical journey in the treatment of diabetes and obesity

Tax-advantaged accounts like flexible savings accounts (FSAs) and health savings accounts (HSAs) can also help

FIB-4 and ELF score are two well-validated biomarkers that assess the risk for liver fibrosis in patients with MASLD

Alcohol accelerates this

One intervention in ORIGIN compared the effect of insulin glargine to standard care on major adverse cardiovascular (CV) outcomes in 12,537 adults 50 years of age with